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Abstract
Introduction: Vaspin (visceral adipose tissue-derived serpin) was first described as an insulin-sensitizing adipose tissue hormone. Recently its an-
ti-inflammatory function has been demonstrated. Since no appropriate data is available yet, we sought to investigate the plasma concentrations of 
vaspin in sepsis. 
Materials and methods: 57 patients in intensive care, fulfilling the ACCP/SCCM criteria for sepsis, were prospectively included in our exploratory 
study. The control group consisted of 48 critically ill patients, receiving intensive care after trauma or major surgery. Patients were matched by age, 
sex, weight and existence of diabetes before statistical analysis. Blood samples were collected on the day of diagnosis. Vaspin plasma concentrations 
were measured using a commercially available enzyme-linked immunosorbent assay.
Results: Vaspin concentrations were significantly higher in septic patients compared to the control group (0.3 (0.1-0.4) ng/mL vs. 0.1 (0.0-0.3) ng/
mL, respectively; P < 0.001). Vaspin concentration showed weak positive correlation with concentration of C-reactive protein (CRP) (r = 0.31, P = 
0.002) as well as with SAPS II (r = 0.34, P = 0.002) and maximum of SOFA (r = 0.39, P < 0.001) scoring systems, as tested for the overall study popu-
lation.
Conclusion: In the sepsis group, vaspin plasma concentration was about three-fold as high as in the median surgical control group. We demon-
strated a weak positive correlation between vaspin and CRP concentration, as well as with two scoring systems commonly used in intensive care 
settings. Although there seems to be some connection between vaspin and inflammation, its role in human sepsis needs to be evaluated further. 
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Sepsis is a major health care problem, responsible 
for approximately 10% of all intensive care unit 
(ICU) admissions. It is associated with long hospi-
talization times and poor patient outcome (1-3). 
Due to recent advances in training and prompt ini-
tiation of anti-microbial therapy, the mortality 
rates of septic shock, which were once as high as 
80 percent, have been reduced to 20 to 30 percent 
(1,4). 
Visceral adipose tissue is suspected to play a 
pathophysiological role in the development of 
systemic inflammation during sepsis. Adipocy-
tokines are cytokines secreted by adipose tissue. A 
sepsis-specific profile of adipocytokines has first 
been reported Hillenbrand and colleagues in 2010 
describing low concentration of adiponectin and 
high concentration of resistin (5). In another study, 
a correlation between these two hormones and 
the severity of the inflammatory response during 
sepsis has been demonstrated (6).
Human visceral adipose tissue–derived serpin (i.e. 
vaspin) is a 47 kDa protein of the serine protease 
inhibitor family. It has been linked with inflamma-
tion, but its exact physiological functions are not 
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yet completely understood. Vaspin was first de-
scribed as an insulin-sensitizing adipocytokine 
(7,8). It is considered to promote insulin secretion 
from pancreatic β-cells (9). Furthermore, it was 
also demonstrated that vaspin influences circulat-
ing levels of the adipocytokines adiponectin and 
resistin in rats (7). Moreover, vaspin inhibits apop-
tosis induced by free fatty acids in vascular en-
dothelial cells (10) and expression of pro-inflam-
matory cytokines (11,12). 
Since no data is yet available concerning the pos-
sible involvement of vaspin in sepsis, we sought to 
investigate vaspin concentration in sepsis by com-
paring the plasma concentrations of the adipocy-
tokine vaspin in patients with sepsis to those of a 
surgical control group also admitted to the ICU. 
Materials and methods
Subjects
This exploratory study was approved by the Ethics 
Committee of the Medical University of Vienna 
and is in accordance to good scientific practice 
and the Helsinki Declaration. We included 57 pa-
tients (35 male patients) with diagnosed sepsis ad-
mitted to our General Intensive Care Units of the 
Department of Anaesthesiology, General Hospital 
of Vienna, Vienna, Austria, over the period from 
July 2010 to March 2013. Sepsis, as systemic inflam-
matory response to infection, was diagnosed us-
ing current criteria as defined by the American 
College of Chest Physicians / Society of Critical 
Care Medicine (ACCP / SCCM) (13). At least two of 
the following symptoms as a result of infection 
need to be present to confirm sepsis diagnosis: 1) 
a body temperature greater than 38 °C or less than 
36 °C, 2) heart rate > 90 beats per minute, 3) res-
piratory rate > 20 breaths per minute or arterial 
concentration of CO2 (pCO2) < 32 mm Hg as an in-
dicator of hyperventilation and 4) white blood leu-
kocyte count (WBC) > 12 x 109/ L or < 4 x 109 / L. 
The control group included 48 patients (37 male 
patients) admitted to the same ICU after major 
surgery (ear-nose-throat-, thoracic-, abdominal or 
orthopaedic surgery). These patients showed no 
evidence of sepsis. 
All patients included were over 18 and under 90 
years of age. Pregnant patients and patients suf-
fering from chronic infectious diseases, such as vi-
ral hepatitis, HIV infection or autoimmune diseases 
were not included. Patients were matched by age, 
sex, weight and existence of diabetes mellitus. 
Study design
On the day of inclusion, blood samples were ob-
tained from each patient. 4.5 mL of venous blood 
was drawn and collected in a 1:10 dilution of 0.11 
M trisodium citrate (BD, New Jersey, USA). Blood 
for samples were drawn in the course of routine 
clinical work. Blood was additionally taken every 
24 hours for up to eight days. Due to organisation-
al difficulties it was not possible to get samples for 
time series analysis from all patients. Samples were 
centrifuged at 3500 rpm for 15 minutes at 4 °C. The 
obtained plasma was stored at -80 °C for up to 1.5 
years until assayed. All samples were thawed si-
multaneously only once. 
Patient-related data such as sex, age, weight, exist-
ence of diabetes mellitus, cause of death, length of 
stay, WBC, concentration of C-reactive protein 
(CRP) and the scores of Simplified Acute Physiolo-
gy Score version II (SAPS II), maximum of Sequen-
tial Organ Failure Assessment (SOFA) within the 
first 24 hours and Acute Physiology and Chronic 
Health Evaluation version II (APACHE II) scoring 
systems (severity of illness scoring systems com-
monly used in intensive care medicine) were ob-
tained from the electronic case documentation 
system used at our clinic. The scoring systems 
used are well established for prognostic categori-
zation of septic patients and take into account var-
ious physiological parameters such as blood pres-
sure, body temperature, heart rate or blood elec-
trolyte concentrations as well as overall function 
of specific organ systems, patient-specific risk fac-
tors such as chronic health impairments or known 
organ dysfunction and necessity of therapeutic in-
tervention (14). As is usual for SOFA scoring, the 
maximum score within the first 24 hours after ad-
mission was taken for analysis (14).
Biochemia Medica 2015;25(1):90–6  http://dx.doi.org/10.11613/BM.2015.011 
92
Motal MC. et al. Plasma vaspin concentration in sepsis
Methods
Vaspin plasma concentration was measured using 
a commercially available enzyme-linked immuno-
sorbent assay (ELISA; Vaspin (human) ELISA Kit, Ad-
ipoGen, Liestal, Switzerland). The manufacturer’s 
coefficient of variation (CV) was 1.31% at vaspin 
plasma concentrations of 0.59 ng/mL, 3.85% at 
0.64 ng/mL and 3.64% at 0.71 ng/mL. Plasma sam-
ples were randomized before assaying and tested 
in duplicates, using a dilution of 1:5 according to 
the manufacturer’s specifications. The assay was 
performed according to the manufacturer’s manu-
al. Photometric readings were performed using a 
Victor 3 Microplate Reader (Perkin Elmer, Waltham, 
USA).
WBC and CRP were quantified at the Department 
of Laboratory Medicine, certified laboratory of the 
Medical University of Vienna, using routine tests. 
WBC values were measured using the Sysmex XE-
5000 hematology analyzer (Sysmex, Kobe, Japan). 
CRP was determined using immunological turbidi-
metric assay (Tina-quant C-reactive protein latex 
high sensitive assay, Roche Diagnostics, Rotkreuz, 
Switzerland). 
Statistical analysis
Statistical analysis was performed using the open 
source statistical package “R version 3.0.2” (R 
Foundation for Statistical Computing, Vienna, Aus-
tria).
For each continuous parameter the Shapiro-Wilks 
normality test was performed. Non-normally dis-
tributed parameters were described using median 
and interquartile range. Since this study was de-
signed as matched case-control study, all compari-
sons were made using tests for paired samples. 
Comparison of groups (sepsis vs. control) was per-
formed using the non-parametric Wilcoxon signed 
rank test, since all data were not normally distrib-
uted. Regarding categorical data, the Pearson Chi-
squared test was used to compare the groups.
To equalize the characteristics (age, sex, weight, 
diabetes mellitus) a genetic matching algorithm 
was applied using the additional package for pa-
tient matching “GenMatch” (15,16) to confirm sig-
nificant differences despite unequal distribution of 
characteristic parameters of both groups. Using 
this non-parametric matching method, optimal 
balance between groups is found using multivari-
ate matching where a genetic search algorithm 
determines the weight each covariate is given. 
Friedman test was used to compare daily vaspin 
plasma concentrations in nine patients for eight 
continuous days.
Results
Table 1 describes our study population’s demo-
graphic details before and after matching using 
GenMatch software.
Plasma vaspin concentration was significantly 
higher in the sepsis group (0.3 (0.1-0.4) ng/mL) 
compared to the surgical control group (0.1 (0.0-
0.3) ng/mL; P < 0.001). Vaspin concentration 
showed weak positive correlation with CRP con-
centration (r = 0.31, P = 0.002), the SAPS II (r = 0.34, 
P = 0.002) and maximum of SOFA (r = 0.39, P < 
0.001) scores, as tested for the overall study popu-
lation. There was no significant correlation be-
tween vaspin and CRP in the septic group alone (r 
= 0.24, P = 0.066). There was a weak, but statisti-
cally significant correlation between vaspin con-
centration and length of stay (r = 0.26, P = 0.009). 
No significant difference in plasma vaspin concen-
trations was observed comparing survivors and 
non-survivors, in the overall study population (P = 
0.33) nor for the septic subgroup alone (P = 0.79). 
Measured vaspin plasma concentration did not 
correlate with APACHE II and WBC, neither for the 
whole of the tested population (APACHE II: r = 0.19, 
P = 0.12; WBC: r = 0.1, P = 0.3) nor for the septic pa-
tients’ (APACHE II: r = -0.08, P = 0.63; WBC: r = 0.07, 
P = 0.59) or control patients’ subsets (APACHE II: r = 
0.02, P = 0.92; WBC: r = -0.15, P = 0.32) alone. Table 
2 shows all calculated correlation data. The time 
series analysis of vaspin plasma concentration of 
nine patients did not show significant changes (P 
= 0.32) over eight consecutive days. Figure 1 shows 
the according plasma concentrations as boxplots.
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Parameter Sepsis ICU controls P
Before matching
Number of patients (N) 57 47 /
Female, N/total 22 / 57 11 / 47 0.091
Age (years) 68 (21- 89) 54 (18-87) < 0.001
Weight (kg) 80 (69.25-95 ) 77 (70-90) 0.508
Patients with diabetes (N) 8 4 0.569
Number of deaths (N) 9 7 0.741
Length of stay (days) 9 (4-17) 3 (1.5-8.5) < 0.001
APACHE II 24 (16.25-28) 17 (17-24) < 0.001
SAPS II 42 (29.5-52.5) 36 (25-53) < 0.001
Maximum of SOFA 6.5 ( 4-10.5) 6 (4-9) < 0.001
Blood leukocyte count (x 109 / L) 14.2 (8.1-18.8) 9.2 (7.6-12.0) 0.019
CRP (mg/L) 17.2 (9.6-28.3) 2.1 (0.3-9.0) < 0.001
Vaspin 1 (ng/mL) 0.3 (0.1-0.5) 0.1 (0.0-0.4) 0.006
After matching
Number of patients (N) 86 86
Female, N/total 27 / 86 26 / 86 1
Age (years) 67 (21-89) 67 (18-87) 0.607
Weight (kg) 80 (70-90) 77.5 (70-90) 0.826
Patients with diabetes (N) 11 10 1
Number of deaths (N) 13 13 1
Length of stay (days) 8 (5-12) 3 (1.25-8) < 0.001
APACHE II 22 (17.25-28) 17 (13-18) < 0.001
SAPS II 42.5 (33-59) 34 (28.75-41) < 0.001
Maximum of SOFA 8 (5-11) 5 (4-8.75) 0.002
Blood leukocyte count (x 109 / L) 8.8 (6.1-16.4) 10.5 (8.5-13.3) 0.355
CRP (mg/L) 15.6 (10.5-22.2) 1.5 (0.2-4.7) < 0.001
Vaspin 1 (ng/mL) 0.3 (0.1-0.4) 0.1 (0.0-0.3) < 0.001
Data is presented as median and intequartile range. Age is given as median (minimum-maximum).
APACHE II - Acute Physiology and Chronic Health Evaluation (2nd version); SAPS II - Simplified Acute Physiology Score (2nd 
version);  Maximum of SOFA - maximum of Sequential Organ Failure Assessment score; CRP - C-reactive protein; Vaspin 1 - Vaspin 
concentration on the day of inclusion. 
Table 1. Study population demographic before and after matching.
Discussion
To the best of our knowledge this is the first report 
of plasma vaspin concentration in patients suffer-
ing from sepsis. Our data show increased concen-
trations of plasma vaspin in sepsis as compared to 
the surgical control group. There was a significant 
correlation between vaspin and CRP for the overall 
group of patients. Moreover, we did find a correla-
tion between the SAPS II and the maximum SOFA 
score with plasma vaspin concentration. Although 
there was a significantly higher plasma concentra-
tion of vaspin in the sepsis group we could not 
find a significant correlation between vaspin and 
CRP, while testing for the septic patient group 
alone. 
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Sepsis is defined as a systemic inflammatory re-
sponse syndrome to infection, where infection ini-
tiates a complex and prolonged host response, in 
which both pro-inflammatory and anti-inflamma-
tory mechanisms occur. Pro-inflammatory cy-
tokines like TNF-α, IL-1β, and IL-6 extend the in-
flammatory cascade, directed at eliminating in-
vading pathogens. However, this inflammation 
may compromise other organ systems (2,3,17). 
Recently, the visceral adipose tissue came to atten-
tion as a source of adipose-derived hormones and 
adipocytokines which may have a role in the de-
velopment of systemic inflammatory response 
during sepsis (5,6,18).
Vaspin is member of the serine protease inhibitor 
family and is expressed in visceral adipose tissue 
of Otsuka Long-Evans Tokushima fatty rats in obe-
sity, when insulin plasma concentrations are high 
(7). In humans, elevated vaspin concentrations are 
associated with obesity as well as impaired insulin 
sensitivity, whereas low vaspin concentration is in-
dicative of a high level of fitness (19). The exact 
mechanisms how vaspin secretion influences the 
glucose metabolism and insulin sensitivity are not 
entirely understood.
We did find significantly increased vaspin plasma 
concentrations in septic patients as compared to 
the control group. However, the mechanism be-
hind higher plasma vaspin concentration was not 
investigated in this study. Since vaspin also exerts 
anti-inflammatory properties, like the suppression 
of TNF-alpha (similar to the inflammatory adipocy-
tokines leptin and resistin) (7), it would be conceiv-
able that the increased vaspin plasma concentra-
tion is a consequence of the increase of pro-in-
flammatory cytokines during sepsis and therefore 
vaspin release belongs to the anti-inflammatory 
mechanisms during sepsis. Interestingly plasma 
vaspin also correlated with the CRP concentration 
in our patients. However, this correlation should 
be interpreted with caution, as it was weak and 
only available for the overall study population. 
These results are in contrast with our previous 
findings: we showed elevated plasma concentra-
tion of zonulin, a protein regulating gut wall per-
meability which is associated with poor insulin 
CRP WBC APACHE II SAPS II SOFAmax






























CRP - C-reactive protein; WBC - white blood cell count. APACHE II - Acute Physiology and Chronic Health Evaluation (2nd version); 
SAPS II - Simplified Acute Physiology Score (2nd version);  Maximum of SOFA - maximum of Sequential Organ Failure Assessment 
score.
Table 2. Correlation of plasma vaspin concentrations with CRP, WBC and severity-of-illness scoring systems.
Figure 1. Vaspin plasma concentration in nine patients for 
eight continuous days.
The box represents first, second and third quartile. Whiskers in-
dicate minimum and maximum. Circles indicate outliers. X-axis 
shows days, Y-axis shows vaspin concentration in ng/mL. Labels 
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sensitivity, in septic patients. For zonulin however, 
there were no correlations between plasma con-
centration and biomarkers of inflammation or se-
verity-of-illness scoring systems (20).
Vaspin, like resistin and adiponectin, correlates 
with the SAPS II and maximum of SOFA scoring 
systems during sepsis (5). We were able to demon-
strate statistically significant correlations of equal 
strength as in the aforementioned study between 
concentration of vaspin and those scores in our 
study patients. 
The present study has some limitations. Vaspin 
concentration was only measured in plasma. As 
there is limited knowledge about molecular tar-
gets, elimination or distribution of vaspin, plasma 
concentration may not be representative of func-
tion or quantity of vaspin in other tissues. 
Since only nine patients were included for time 
line analysis, this sample size is too small for prop-
er inference about the dynamics of vaspin concen-
trations after the first day of diagnosis of sepsis. 
We also state that some of our septic patients have 
been included in our previous study exploring 
zonulin plasma concentrations as a potential mark-
er for gut wall integrity in sepsis. However, aliquot-
ed samples were only used once. Lastly, as the re-
cruitment of patients lasted for 1.5 years, unknown 
stability issues could affect the measurement of 
vaspin.
In conclusion, our data provide evidence that plas-
ma vaspin concentration is significantly increased 
in septic patients as compared to non-septic ICU 
patients. Vaspin release may belong to the anti-in-
flammatory mechanisms during sepsis. Our re-
sults, however, warrant further larger clinical stud-
ies to elucidate vaspin’s function during sepsis, es-
pecially the role of vaspin in the monitoring of the 
course and severity of the disease.
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